🟠 Moderate Evidence
- Substantial Gap Between Development and Clinical Deployment
- Which Conditions Are Covered by These Predictive Tools?
- Understanding Barriers to Implementation
- Frequently asked questions
- What types of predictive health tools exist in Australia?
- Why are these tools not being used in routine clinical care?
- What would it take to increase adoption of these predictive tools?
- Bridging the Gap: Next Steps for Australian Health Systems
Australia has developed a growing portfolio of predictive health tools capable of identifying patients at risk of serious conditions—including heart disease, falls, frailty, and diabetes complications—yet adoption in routine clinical care remains sparse, according to a systematic review published in The Lancet Regional Health – Western Pacific. Researchers from Curtin University found a substantial gap between health innovation and real-world implementation, raising questions about how promising technologies reach frontline clinical services.
Key takeaways
- Australia has developed numerous predictive risk tools for conditions such as heart disease, falls, frailty, and diabetes complications
- Very few of these tools are being routinely implemented in everyday health care settings
- The innovation-to-practice gap represents a significant disconnect between research development and clinical adoption
- Addressing barriers to implementation could improve early identification and prevention of serious health events
Study at a Glance
| Source | The Lancet Regional Health – Western Pacific |
| Study type | Systematic review |
| Institution | Curtin University, Australia |
| Focus | Predictive health tools and clinical adoption patterns |
| Country | Australia |
The Innovation-to-Implementation Divide in Predictive Health Tools
Gap between development and routine clinical adoption in Australia
Source: Curtin University review, The Lancet Regional Health – Western Pacific | Georgian Medical Journal News
Substantial Gap Between Development and Clinical Deployment
The Curtin University systematic review documented that while Australian institutions have created predictive risk assessment tools across multiple disease categories, implementation in health services remains limited. This disconnect—between what researchers develop in controlled academic settings and what clinicians actually use in daily practice—represents a critical challenge in translating innovation into patient benefit.
The findings underscore a well-documented problem in health systems: promising evidence-based tools often fail to cross the threshold from research to routine care. For a comprehensive overview of clinical updates and adoption challenges, see GMJ News’s coverage of implementation barriers in modern health systems.
Which Conditions Are Covered by These Predictive Tools?
According to the Curtin University review, the portfolio of Australian-developed predictive tools spans several high-burden conditions. These include cardiovascular disease risk prediction, identification of patients at high risk of falls, assessment of frailty progression, and early detection of diabetes complications—all conditions where early intervention can substantially improve outcomes.
The existence of these tools demonstrates genuine clinical and research innovation capacity within Australian institutions. However, their shelf-life in research institutions rather than patient care settings suggests barriers beyond mere technical limitations. Clinicians and health services may face logistical, financial, or workflow-related obstacles to integration.
Australia has developed a growing number of predictive health tools for serious conditions, yet very few are being routinely used by health services, representing a major gap between innovation and patient care delivery.
— Curtin University research team (The Lancet Regional Health – Western Pacific)
Understanding Barriers to Implementation
The innovation-to-practice gap identified by Curtin researchers points to multiple potential barriers. These may include insufficient clinician awareness, lack of integration with existing electronic health record systems, unclear evidence on cost-effectiveness in real-world settings, regulatory hurdles, or simply the inertia inherent in complex health systems. Understanding which barriers are most significant would require further investigation beyond the scope of this systematic review.
For further context on health policy and implementation challenges, GMJ News has covered similar adoption barriers in other health technology domains. The Australian experience reflects patterns seen internationally: promising tools developed without adequate planning for clinical integration.
What this means
Frequently asked questions
What types of predictive health tools exist in Australia?
According to the Curtin University systematic review published in The Lancet Regional Health – Western Pacific, Australian-developed tools include instruments for predicting cardiovascular disease risk, identifying patients at risk of falls, assessing frailty, and detecting early diabetes complications. These tools employ statistical models or algorithmic approaches to stratify patients by risk level before clinical events occur.
Why are these tools not being used in routine clinical care?
The review identifies a gap but does not specify the precise barriers. However, common obstacles to health technology adoption include insufficient clinical awareness, lack of integration with electronic health record systems, unclear cost-benefit analysis in real-world settings, workflow disruption, and regulatory complexity. Each tool may face distinct implementation challenges requiring targeted solutions.
What would it take to increase adoption of these predictive tools?
Effective implementation likely requires multifaceted strategies: demonstrating cost-effectiveness in Australian health contexts, integrating tools into existing clinical workflows and electronic systems, training clinicians on proper use, establishing reimbursement pathways, and engaging health system leadership. Implementation science frameworks, not just research evidence, are critical to translating innovation into practice.
Bridging the Gap: Next Steps for Australian Health Systems
Closing the innovation-to-implementation divide requires coordinated action across research institutions, health services, regulators, and policymakers. The Curtin University findings should prompt investigation into which specific barriers—technical, financial, regulatory, or cultural—are preventing adoption of each tool. Health systems that systematically address these barriers, supported by implementation science and adequate funding, are more likely to realize the preventive benefits these predictive tools promise. The opportunity exists; translating it into routine care depends on deliberate, evidence-based adoption strategies.
Source: Australians missing out on ‘major gap’ between innovation and patient care
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
